ArriVent BioPharma AVBP
NASDAQ AVBP
$13.51 +0.02 (+0.11%)
At close: Nov 11, 2026 · 4:00 PM EST

ArriVent BioPharma (AVBP) Long-Term Investments (2024 - 2025)

Updated

ArriVent BioPharma (AVBP) posted Long-Term Investments of $5.11 million for Q3 2025, down 72.8% from the prior quarter.

Analysis

ArriVent BioPharma (AVBP) Long-Term Investments (2024 - 2025) Analysis & Trends

At the end of FY2024, ArriVent BioPharma's Long-Term Investments came in at $47.68 million.

  • According to Business Quant data, Long-Term Investments for the three prior quarters was $18.79 million (Q2 2025), $29.41 million (Q1 2025) and $47.68 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 ArriVent BioPharma 690.85 Mn -714.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 5.11 Mn
Jun 30, 2025 18.79 Mn
Mar 31, 2025 29.41 Mn
Dec 31, 2024 47.68 Mn
API Access

ArriVent BioPharma Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=AVBP&period=max&api_key=YOUR_API_KEY